FDA official logo
GSRS logoPFDA official logo

DARIFENACIN HYDROBROMIDE

UNII:CR02EYQ8GV
Formula:C28H30N2O2.BrH
Preferred Substance Name:DARIFENACIN HYDROBROMIDE
InChIKey:UQAVIASOPREUIT-VQIWEWKSSA-N

  • 133099-07-7
  • (S)-2-(1-(2-(2,3-DIHYDROBENZOFURAN-5-YL)ETHYL)-3-PYRROLIDNYL)-2,2-DIPHENYLACETAMIDE HBR
  • (S)-2-(1-(2-(2,3-DIHYDROBENZOFURAN-5-YL)ETHYL)-3-PYRROLIDNYL)-2,2-DIPHENYLACETAMIDE HYDROBROMIDE
  • 3-PYRROLIDINEACETAMIDE, 1-(2-(2,3-DIHYDRO-5-BENZOFURANYL)ETHYL)-.ALPHA.,.ALPHA.-DIPHENYL-, MONOHBR, (3S)-
  • 3-PYRROLIDINEACETAMIDE, 1-(2-(2,3-DIHYDRO-5-BENZOFURANYL)ETHYL)-.ALPHA.,.ALPHA.-DIPHENYL-, MONOHYDROBROMIDE, (3S)-
  • DARIFENACIN HBR
  • DARIFENACIN HYDROBROMIDE [EMA EPAR]
  • DARIFENACIN HYDROBROMIDE [JAN]
  • DARIFENACIN HYDROBROMIDE [MART.]
  • DARIFENACIN HYDROBROMIDE [MI]
  • DARIFENACIN HYDROBROMIDE [ORANGE BOOK]
  • DARIFENACIN HYDROBROMIDE [USAN]
  • DARIFENACIN HYDROBROMIDE [USP-RS]
  • DARIFENACIN HYDROBROMIDE [WHO-DD]
  • EMSELEX
  • ENABLEX
  • UK-88525-04 (HBR)
  • UK-88525-04 (HYDROBROMIDE)



UNII - CR02EYQ8GV | UNII Search Service